Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1957;15:889-896

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BAKER, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BAKER, S. P.

(Circulation. 1957;15:889.)
© 1957 American Heart Association, Inc.


Heparin-Activated Clearing Factor

Standardized Test, Agewise Application, and Clinical Observations

SAUL P. BAKER M.D.1

1 From the Gerontology Branch, National Heart Institute, National Institutes of Health, U.S. Public Health Service, Bethesda, and the Baltimore City Hospitals, Baltimore, Md.

A possible relationship may exist between the concentration of heparin-activated plasma clearing factor and alterations in lipid metabolism associated with advancing age, atherosclerosis, and other diseases. To test this hypothesis, 121 men were evaluated in the development and application of a standardized in vitro method for the determination of clearing factor response to minimal heparin stimulation. Eighty-four men, ranging from 21 to 93 years, selected from this group, were evaluated in an age-wise study. Patients with diagnoses of recent myocardial infarction (presumptive evidence of coronary atherosclerosis), cirrhosis of the liver, and chronic alcoholism were also tested.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
H. E. Shaftel and E. Padernacht
The Effect of Continued Administration of Sublingual Heparin On the Fat Tolerance Test
Angiology, April 1, 1961; 12(4): 124 - 126.
[PDF]


Home page
ANGIOLOGYHome page
C.N. Mangieri and R.A. Cain
Demonstration of Lipemia-Clearing Activity After Sublingual Administration of Heparin Potassium in the Rabbit
Angiology, April 1, 1961; 12(4): 136 - 138.
[PDF]


Home page
ANGIOLOGYHome page
H. E. Shaftel and D. Selman
The Effect of Sublingual Heparin On Hyperlipemic Serum
Angiology, June 1, 1959; 10(3): 131 - 133.
[PDF]


Home page
ANGIOLOGYHome page
H. L. Fuller
Sublingual Heparin in Hyperlipemia: A Preliminary Report
Angiology, October 1, 1958; 9(5): 311 - 313.
[PDF]


Home page
Arch Intern MedHome page
M. P. SAMBHI and H. A. ZIMMERMAN
Progress in the Long-Term Management of Coronary Artery Disease
Arch Intern Med, May 1, 1958; 101(5): 974 - 996.
[Abstract] [PDF]